StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
13
Publishing Date
2021 - 03 - 01
1
2021 - 02 - 28
1
2021 - 02 - 23
1
2021 - 02 - 22
2
2021 - 02 - 01
3
2021 - 01 - 25
1
2021 - 01 - 08
1
2020 - 12 - 28
1
2020 - 12 - 21
1
2020 - 12 - 11
1
Sector
Health technology
13
Tags
Acquisition
4
Annual needham
4
Application
5
Approval
10
Awards
5
Battery
5
Bioconnect 2021 conference
6
Bioscience
11
Biotech
9
Ceo
4
Chronic hepatitis b
4
Collaboration
5
Commercialization
11
Conference
31
Contract
7
Covid
6
Designation
4
Diagnostic
4
Disease
7
Distribution
4
Drug
7
Energy
10
Enroll
4
Ev
5
Expansion
6
Fda
13
Fda approval
5
Financial results
30
Gene therapies
4
Gene therapy
4
Granted
4
Growth
8
Health
15
Hepatitis
4
Insurance
4
Iot
4
J.p. morgan healthcare conference
16
Leo
4
Life science
15
Liver
5
Milestone
5
Molecular
5
N/a
464
Nasdaq
7
Offering
10
Patent
5
Pharma
15
Phase 2
9
Presentation
14
Program
8
Rare
5
Research
7
Results
70
Solar
6
Svb leerink global
7
Symposium
5
Therapeutics
21
Therapy
16
Treatment
14
Trial
15
Entities
Adma biologics inc
1
Albireo pharma, inc.
1
Avadel pharmaceuticals plc
1
Bridgebio pharma, inc.
1
Cns pharmaceuticals, inc.
1
Inari medical, inc.
1
Intra-cellular therapies inc.
1
Lexicon pharmaceuticals, inc.
1
Onconova therapeutics, inc.
1
Scpharmaceuticals inc.
1
Supernus pharmaceuticals, inc.
1
Vyne therapeutics inc.
1
Zosano pharma corporation
1
Symbols
ADMA
1
ALBO
1
AVDL
1
BBIO
1
CNSP
1
ITCI
1
LXRX
1
NARI
1
ONTX
1
SCPH
1
SUPN
1
VYNE
1
ZSAN
1
Exchanges
Nasdaq
13
Crawled Date
2021 - 03 - 01
1
2021 - 02 - 28
1
2021 - 02 - 23
1
2021 - 02 - 22
2
2021 - 02 - 01
3
2021 - 01 - 25
1
2021 - 01 - 08
1
2020 - 12 - 28
1
2020 - 12 - 21
1
2020 - 12 - 11
1
Crawled Time
00:00
71
00:20
12
01:00
52
02:00
14
03:00
9
04:00
6
04:20
5
05:00
17
06:00
30
06:03
3
07:00
38
08:00
20
08:20
6
09:00
22
09:08
4
10:00
28
10:21
3
10:41
3
11:00
182
12:00
484
12:01
4
12:03
15
12:07
5
12:15
36
12:20
94
12:30
72
12:58
4
13:00
423
13:01
7
13:03
13
13:05
3
13:15
25
13:20
88
13:30
81
13:35
3
13:47
4
14:00
308
14:01
6
14:04
4
14:15
11
14:20
45
14:27
4
14:30
68
15:00
177
15:15
10
15:20
20
15:30
51
16:00
88
16:19
3
16:20
5
17:00
99
18:00
93
18:03
3
18:58
4
19:00
90
20:00
114
21:00
146
22:00
133
22:01
8
23:00
131
Source
www.globenewswire.com
13
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Fda
crawled time :
13:03
save search
Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for FT218 in Adults with Narcolepsy for the Treatment of Excessive Daytime Sleepiness and Cataplexy
Published:
2021-03-01
(Crawled : 13:03)
- globenewswire.com
AVDL
|
$18.075
4.48%
4.29%
990K
|
Health Technology
|
125.0%
|
O:
0.75%
H:
4.57%
C:
2.22%
new drug
treatment
fda
drug
ft218
fda acceptance
narcolepsy
BridgeBio Pharma and Affiliate Origin Biosciences Announce FDA Approval of NULIBRY™ (fosdenopterin), the First and Only Approved Therapy to Reduce the Risk of Mortality in Patients with MoCD Type A
Published:
2021-02-28
(Crawled : 13:03)
- globenewswire.com
BBIO
|
$25.43
1.44%
1.42%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
fda
risk
fda approval
therapy
approval
scPharmaceuticals Inc. Announces Results of Type A End-of-Review Meeting with FDA Regarding FUROSCIX® NDA
Published:
2021-02-23
(Crawled : 13:03)
- globenewswire.com
SCPH
|
$4.6
0.66%
0.65%
85K
|
Health Technology
|
-33.38%
|
O:
-0.14%
H:
2.56%
C:
0.43%
fda
results
Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression
Published:
2021-02-22
(Crawled : 13:03)
- globenewswire.com
ITCI
4 d
|
$73.96
-0.78%
-0.78%
830K
|
Health Technology
|
87.32%
|
O:
1.19%
H:
0.06%
C:
-2.53%
treatment
fda
fda approval
depression
approval
therapy
Supernus Receives FDA Notice Assigning Early April 2021 PDUFA Date for SPN-812 NDA
Published:
2021-02-22
(Crawled : 13:03)
- globenewswire.com
SUPN
|
$29.98
0.91%
0.9%
200K
|
Health Technology
|
1.15%
|
O:
0.03%
H:
0.91%
C:
-1.22%
fda
pdufa
Zosano Pharma Announces NDA Resubmission Plans Following Type A Meeting with FDA
Published:
2021-02-01
(Crawled : 13:03)
- globenewswire.com
ZSAN
|
$0.5576
7.23%
-5.85%
|
Health Technology
|
-98.27%
|
O:
21.77%
H:
0.0%
C:
-12.5%
fda
submission
resubmission
pharma
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN
Published:
2021-02-01
(Crawled : 13:03)
- globenewswire.com
ADMA
4
|
$6.535
5.4%
5.13%
2.7M
|
Health Technology
|
194.59%
|
O:
5.86%
H:
5.53%
C:
4.26%
fda approval
fda
approval
VYNE Therapeutics Announces FDA Approval of AMZEEQ® (Minocycline) Label Update
Published:
2021-02-01
(Crawled : 13:03)
- globenewswire.com
VYNE
|
$2.345
-0.21%
-0.21%
30K
|
Health Technology
|
-70.71%
|
O:
6.06%
H:
11.9%
C:
9.52%
fda approval
fda
approval
therapeutics
Albireo Announces U.S. FDA Acceptance of New Drug Application for Odevixibat
Published:
2021-01-25
(Crawled : 13:03)
- globenewswire.com
ALBO
|
$44.15
-0.23%
0.39%
1.2M
|
Health Technology
|
26.21%
|
O:
4.34%
H:
3.88%
C:
-0.55%
fda
drug
fda acceptance
new drug
application
Inari Medical’s FlowTriever System Receives FDA 510(k) Clearance for Treatment of Right Atrial Clot in Transit
Published:
2021-01-08
(Crawled : 13:03)
- globenewswire.com
NARI
S
|
$37.13
-2.11%
-2.15%
1.5M
|
Health Technology
|
-54.22%
|
O:
1.38%
H:
2.66%
C:
2.31%
fda
trial
treatment
clearance
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent FDA Approval of IND Application
Published:
2020-12-28
(Crawled : 13:03)
- globenewswire.com
CNSP
|
News
|
$0.201
0.95%
0.95%
120K
|
Health Technology
|
-88.2%
|
O:
1.8%
H:
4.86%
C:
2.1%
fda approval
fda
approval
broadcast
application
Onconova Therapeutics Announces FDA Permission for Study to Proceed Under its Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor ON 123300
Published:
2020-12-21
(Crawled : 13:03)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
163.16%
|
O:
7.89%
H:
0.98%
C:
-11.24%
fda
drug
new drug
application
Lexicon Pharmaceuticals Receives Fast Track Designation From the FDA for LX9211 for Diabetic Peripheral Neuropathic Pain
Published:
2020-12-11
(Crawled : 13:03)
- globenewswire.com
LXRX
|
$1.62
-5.26%
-5.56%
3.5M
|
Health Technology
|
-51.51%
|
O:
22.59%
H:
0.74%
C:
-23.34%
fda
diabetic
diabetes
fast track
fast track designation
designation
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.